{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:47:02Z","timestamp":1793252822055,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007174","name":"Pfizer Inc Boulder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jgar.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:40:33Z","timestamp":1652481633000},"page":"371-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression"],"prefix":"10.1016","volume":"29","author":[{"given":"Mariana","family":"Castanheira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-1132","authenticated-orcid":false,"given":"Lalitagauri M.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-6087","authenticated-orcid":false,"given":"Andrew P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia G.","family":"Carvalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pfaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.05.004_bib0001","doi-asserted-by":"crossref","first-page":"e01811","DOI":"10.1128\/JCM.01811-20","article-title":"Name changes for fungi of medical importance, 2018 to 2019","volume":"59","author":"Borman","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0002","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jgar.2022.05.004_bib0003","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997\u20132016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.004_bib0004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2022.05.004_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candidaglabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2022.05.004_bib0006","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3389\/fmicb.2016.01995","article-title":"Genetic drivers of multidrug resistance in Candida glabrata","volume":"7","author":"Healey","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0007","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jgar.2022.05.004_bib0008","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.004_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed Candidemia: four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jgar.2022.05.004_bib0010","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2958.2008.06143.x","article-title":"The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata","volume":"68","author":"Torelli","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0012","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","article-title":"Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata","volume":"42","author":"Miyazaki","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0013","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01271-10","article-title":"Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice","volume":"55","author":"Ferrari","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0016","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijantimicag.2008.11.011","article-title":"Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia","volume":"33","author":"Berila","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.05.004_bib0017","first-page":"2173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0019","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11046-012-9551-x","article-title":"Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance program","volume":"174","author":"Pfaller","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2022.05.004_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01686-12","article-title":"Candida guilliermondii and other species of Candida misidentified as Candida famata: assessment by Vitek2, ITS sequence analysis and matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry in two global surveillance programs","volume":"51","author":"Castanheira","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0021","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.jgar.2022.05.004_bib0022","series-title":"Epidemiological Cutoff Values for antifungal susceptibility testing","year":"2016"},{"key":"10.1016\/j.jgar.2022.05.004_bib0023","series-title":"Performance standards for antifungal susceptibility of testing yeasts","year":"2018"},{"key":"10.1016\/j.jgar.2022.05.004_bib0024","unstructured":"Joshi N, Fass JN. Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files (version 1.33). https:\/\/github.com\/najoshi\/sickle; 2011. Accessed 30 September 2019."},{"issue":"1","key":"10.1016\/j.jgar.2022.05.004_bib0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2164-14-S1-S7","article-title":"BayesHammer: Bayesian clustering for error correction in single-cell sequencing","volume":"14","author":"Nikolenko","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jgar.2022.05.004_bib0026","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/JCM.41.12.5709-5717.2003","article-title":"Multilocus sequence typing of Candida glabrata reveals geographically enriched clades","volume":"41","author":"Dodgson","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0027","unstructured":"Centers for Disease Control and Prevention. Drug-resistant Candida species. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/candida-508.pdf; 2019. Accessed 30 August 2019."},{"key":"10.1016\/j.jgar.2022.05.004_bib0028","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.004_bib0029","doi-asserted-by":"crossref","first-page":"e02031","DOI":"10.1128\/AAC.02031-20","article-title":"Evaluation of synergistic activity of isavuconazole or voriconazole plus anidulafungin and the occurrence and genetic characterization of Candida auris detected in a surveillance program","volume":"65","author":"Pfaller","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0030","doi-asserted-by":"crossref","first-page":"e00906","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and moulds: Application of CLSI epidemiological cutoff values and whole genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0031","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0032","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/mmy\/myz014","article-title":"Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains","volume":"58","author":"Navarro-Rodriguez","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2022.05.004_bib0033","doi-asserted-by":"crossref","first-page":"e01070","DOI":"10.1128\/AAC.01070-18","article-title":"Relative contribution of the ABC transporters Cdr1, Pdh1, and Snq2 to azole resistance in Candida glabrata","volume":"62","author":"Whaley","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0034","doi-asserted-by":"crossref","first-page":"e00554","DOI":"10.1128\/AAC.00554-20","article-title":"Candida glabrata transcription factor Rpn4 mediates fluconazole resistance through regulation of ergosterol biosynthesis and plasma membrane permeability","volume":"64","author":"Pais","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/jof4030105","article-title":"Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata","volume":"4","author":"Healey","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jgar.2022.05.004_bib0036","doi-asserted-by":"crossref","first-page":"e00591","DOI":"10.1128\/AAC.00591-18","article-title":"Clonal spread of Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium","volume":"62","author":"Goemaere","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0037","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3201\/eid2703.203482","article-title":"Fluconazole-resistant Candida glabrata bloodstream isolates, South Korea, 2008\u20132018","volume":"27","author":"Won","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.004_bib0038","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.00479-10","article-title":"Risk factors for fluconazole-resistant candidemia","volume":"54","author":"Garnacho-Montero","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.004_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.004_bib0040","series-title":"Performance standards for antifungal susceptibility testing of yeasts","year":"2020"},{"key":"10.1016\/j.jgar.2022.05.004_bib0041","series-title":"Performance standards for antifungal susceptibility testing of filamentous fungi","year":"2020"},{"key":"10.1016\/j.jgar.2022.05.004_bib0042","series-title":"Epidemiological Cutoff Values for antifungal susceptibility testing","year":"2020"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:58:35Z","timestamp":1761991115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":42,"alternative-id":["S2213716522001084"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.05.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}